Nucleus Global
Nucleus Global is seeking a Scientific Director to lead scientific content development, strategy, and new business efforts within the medical communications space. The role involves collaborating with experts, developing impactful educational content, and building relationships with stakeholders, all within a flexible work environment.
Headquarters
London, England, United Kingdom
Company Size
501-1000 employees
Founded
1986
Nucleus Global is a pharmaceutical and medical communications agency that helps biotech, pharmaceutical and healthcare organisations share scientific and clinical evidence with stakeholders worldwide. They use a science‑first, evidence‑driven approach to deliver integrated services such as publications and medical affairs strategies, congress support, medical education, HEOR, and digital engagement across the product lifecycle. Cross‑functional teams of medical writers, strategists, creatives and digital specialists translate complex data into clear, compliant communications to support launches, uptake and ongoing stakeholder engagement. The agency emphasises bold strategic thinking and global reach to “share science with the world.”
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nucleus Global.
Huntsworth adds Big Pharma-focused medical communications group Nucleus Global to its network
Nov 12, 2020
Director, Global Medical Information & Scientific Communications
allogene
Director, Scientific Communications
Insmed Incorporated
Scientific Director (Oncology)
MJH Life Sciences®
Scientific Director
Built In NYC
Associate Director, Global Scientific & Value Content - Payor (AD, GSVC-Payor)
Merck & Co., Inc.
Associate Director/Director, Scientific Communications
Cognito Therapeutics